Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Posner

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Journal of Comparative Effectiveness Research|November 19, 2013
The SPECTRUM of findings in treatment options for recurrent/metastatic head and neck cancerKrzysztof Misiukiewicz, Marshall Posner
Oncology (Williston Park, N.Y.)|June 5, 2012
Time to change the treatment paradigms in anaplastic thyroid carcinomaKrzysztof Misiukiewicz, Marshall Posner
International Journal of Radiation Oncology, Biology, Physics|December 17, 2016
Robotic Surgery plus Chemo-Radiation TherapyMarshall Posner, Vishal Gupta
Iscience|April 5, 2021
Interdisciplinary case study: from fly-to-bedside, translating basic research to the clinicMarshall Posner, Ross Cagan
Seminars in Oncology|June 12, 2008
Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancerMarshall Posner, Jan B Vermorken
The Lancet. Oncology|February 29, 2024
Endpoints in human papillomavirus-related oropharyngeal cancer trialsMarshall Posner, Scott A Roof
Expert Opinion on Emerging Drugs|August 31, 2006
Emerging drugs for head and neck cancerRobert Haddad, Lori Wirth, Marshall Posner
The Oncologist|August 15, 2008
Radiation treatment breaks and ulcerative mucositis in head and neck cancerGregory Russo, Robert Haddad, Marshall Posner, et al.
Oral Oncology|August 6, 2014
Psychological distress in patients and caregivers over the course of radiotherapy for head and neck cancerHoda Badr, Vishal Gupta, Andrew Sikora, et al.
The Lancet. Oncology|November 27, 2025
Misclassification of p16-positive, HPV-negative patients biases de-escalation trialsJessica T Lovett, Michael T Wotman, Marshall Posner
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Journal of Comparative Effectiveness Research|November 19, 2013
The SPECTRUM of findings in treatment options for recurrent/metastatic head and neck cancerKrzysztof Misiukiewicz, Marshall Posner
Oncology (Williston Park, N.Y.)|June 5, 2012
Time to change the treatment paradigms in anaplastic thyroid carcinomaKrzysztof Misiukiewicz, Marshall Posner
International Journal of Radiation Oncology, Biology, Physics|December 17, 2016
Robotic Surgery plus Chemo-Radiation TherapyMarshall Posner, Vishal Gupta
Iscience|April 5, 2021
Interdisciplinary case study: from fly-to-bedside, translating basic research to the clinicMarshall Posner, Ross Cagan
Seminars in Oncology|June 12, 2008
Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancerMarshall Posner, Jan B Vermorken
The Lancet. Oncology|February 29, 2024
Endpoints in human papillomavirus-related oropharyngeal cancer trialsMarshall Posner, Scott A Roof
Expert Opinion on Emerging Drugs|August 31, 2006
Emerging drugs for head and neck cancerRobert Haddad, Lori Wirth, Marshall Posner
The Oncologist|August 15, 2008
Radiation treatment breaks and ulcerative mucositis in head and neck cancerGregory Russo, Robert Haddad, Marshall Posner, et al.
Oral Oncology|August 6, 2014
Psychological distress in patients and caregivers over the course of radiotherapy for head and neck cancerHoda Badr, Vishal Gupta, Andrew Sikora, et al.
The Lancet. Oncology|November 27, 2025
Misclassification of p16-positive, HPV-negative patients biases de-escalation trialsJessica T Lovett, Michael T Wotman, Marshall Posner
Pageof 10